Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.

Mayo Clinic researchers have developed a promising gene-editing therapy that directly corrects a genetic mutation responsible ...

SAN FRANCISCO, Nov. 5, 2025 /PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D.

SAN DIEGO - Regulus Therapeutics Inc . (NASDAQ:RGLS), a biopharmaceutical company currently trading at $1.17 per share, today announced significant clinical and regulatory advancements in its ...

A study of real-world patients with ADPKD supports tolvaptan’s role in slowing annual eGFR decline. Treatment with tolvaptan modestly but significantly attenuates long-term decline of kidney function ...

SAN DIEGO, Oct. 19, 2023 /PRNewswire/ -- Regulus Therapeutics Inc. (RGLS) (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting ...

Please provide your email address to receive an email when new articles are posted on . Infection rates stayed within International Society for Peritoneal Dialysis guideline thresholds during the ...

SAN DIEGO, June 27, 2023 /PRNewswire/ -- Regulus Therapeutics Inc. (RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the ...

In this study, the rate of ICA was more than twice as high among those with ADPKD compared with those with another primary nephrological diagnosis. Patient education—including knowledge about risk ...